110 related articles for article (PubMed ID: 27679509)
1. Activation of the Wnt/β-catenin pathway is common in wilms tumor, but rarely through β-catenin mutation and APC promoter methylation.
Schweigert A; Fischer C; Mayr D; von Schweinitz D; Kappler R; Hubertus J
Pediatr Surg Int; 2016 Dec; 32(12):1141-1146. PubMed ID: 27679509
[TBL] [Abstract][Full Text] [Related]
2. Deregulation of Wnt/β-catenin signaling through genetic or epigenetic alterations in human neuroendocrine tumors.
Kim JT; Li J; Jang ER; Gulhati P; Rychahou PG; Napier DL; Wang C; Weiss HL; Lee EY; Anthony L; Townsend CM; Liu C; Evers BM
Carcinogenesis; 2013 May; 34(5):953-61. PubMed ID: 23354304
[TBL] [Abstract][Full Text] [Related]
3. The clinical significance of adenomatous polyposis coli (APC) and catenin Beta 1 (CTNNB1) genetic aberrations in patients with melanoma.
Karachaliou GS; Alkallas R; Carroll SB; Caressi C; Zakria D; Patel NM; Trembath DG; Ezzell JA; Pegna GJ; Googe PB; Galeotti JP; Ayvali F; Collichio FA; Lee CB; Ollila DW; Gulley ML; Johnson DB; Kim KB; Watson IR; Moschos SJ
BMC Cancer; 2022 Jan; 22(1):38. PubMed ID: 34986841
[TBL] [Abstract][Full Text] [Related]
4. Association of APC Expression with Its Promoter Methylation Status and the Prognosis of Hepatocellular Carcinoma.
Xing W; Li Y; Chen J; Hu Q; Liu P; Ge X; Lv J; Wang D
Asian Pac J Cancer Prev; 2023 Nov; 24(11):3851-3857. PubMed ID: 38019243
[TBL] [Abstract][Full Text] [Related]
5. An oncogenic CTNNB1 mutation is predictive of post-operative recurrence-free survival in an EGFR-mutant lung adenocarcinoma.
Kim Y; Ahn B; Yoon S; Lee G; Kim D; Chun SM; Kim HR; Jang SJ; Hwang HS
PLoS One; 2023; 18(6):e0287256. PubMed ID: 37347751
[TBL] [Abstract][Full Text] [Related]
6. Stromal β-catenin activation impacts nephron progenitor differentiation in the developing kidney and may contribute to Wilms tumor.
Drake KA; Chaney CP; Das A; Roy P; Kwartler CS; Rakheja D; Carroll TJ
Development; 2020 Jul; 147(21):. PubMed ID: 32541007
[TBL] [Abstract][Full Text] [Related]
7. The ubiquitin ligase HUWE1 enhances WNT signaling by antagonizing destruction complex-mediated β-catenin degradation and through a mechanism independent of β-catenin stability.
McKenna JK; Wu Y; Sonkusre P; Chari R; Lebensohn AM
bioRxiv; 2024 Mar; ():. PubMed ID: 38410441
[TBL] [Abstract][Full Text] [Related]
8. Activation of the Wnt/β-catenin signaling pathway and CTNNB1 mutations in canine intestinal epithelial proliferative lesions.
Ishikawa K; Chambers JK; Uchida K
J Vet Med Sci; 2024 May; ():. PubMed ID: 38811188
[TBL] [Abstract][Full Text] [Related]
9. The Wnt/β-catenin pathway in human fibrotic-like diseases and its eligibility as a therapeutic target.
Enzo MV; Rastrelli M; Rossi CR; Hladnik U; Segat D
Mol Cell Ther; 2015; 3():1. PubMed ID: 26056602
[TBL] [Abstract][Full Text] [Related]
10. Quantitative live-cell imaging and computational modeling shed new light on endogenous WNT/CTNNB1 signaling dynamics.
de Man SM; Zwanenburg G; van der Wal T; Hink MA; van Amerongen R
Elife; 2021 Jun; 10():. PubMed ID: 34190040
[TBL] [Abstract][Full Text] [Related]
11. A Mosaic Variant in CTNNB1/β-catenin as a Novel Cause for Osteopathia Striata With Cranial Sclerosis.
Huybrechts Y; Appelman-Dijkstra NM; Steenackers E; Van Beylen W; Mortier G; Hendrickx G; Van Hul W
J Clin Endocrinol Metab; 2024 Jun; 109(7):1891-1898. PubMed ID: 38173341
[TBL] [Abstract][Full Text] [Related]
12. CTNNB1 somatic mutations drive Wnt pathway activation in a case of incidental intranodal palisaded myofibroblastoma.
Moreno de Juan G; Montes Moreno S
Rev Esp Patol; 2023; 56(4):279-283. PubMed ID: 37879826
[TBL] [Abstract][Full Text] [Related]
13. Exploiting differential Wnt target gene expression to generate a molecular biomarker for colorectal cancer stratification.
Kleeman SO; Koelzer VH; Jones HJ; Vazquez EG; Davis H; East JE; Arnold R; Koppens MA; Blake A; Domingo E; Cunningham C; Beggs AD; Pestinger V; Loughrey MB; Wang LM; Lannagan TR; Woods SL; Worthley D; Consortium SC; Tomlinson I; Dunne PD; Maughan T; Leedham SJ
Gut; 2020 Jun; 69(6):1092-1103. PubMed ID: 31563876
[TBL] [Abstract][Full Text] [Related]
14. SMARCA4 Loss and Mutated β-Catenin Induce Proliferative Lesions in the Murine Embryonic Cerebellum.
Göbel C; Schoof M; Holdhof D; Spohn M; Schüller U
J Neurosci; 2024 Apr; 44(15):. PubMed ID: 38383496
[TBL] [Abstract][Full Text] [Related]
15. Genetic interactions of the androgen and Wnt/beta-catenin pathways for the masculinization of external genitalia.
Miyagawa S; Satoh Y; Haraguchi R; Suzuki K; Iguchi T; Taketo MM; Nakagata N; Matsumoto T; Takeyama K; Kato S; Yamada G
Mol Endocrinol; 2009 Jun; 23(6):871-80. PubMed ID: 19282366
[TBL] [Abstract][Full Text] [Related]
16. APC and AXIN2 Are Promising Biomarker Candidates for the Early Detection of Adenomas and Hyperplastic Polyps.
Rezasoltani S; Hadizadeh M; Golmohammadi M; Nazemalhossini-Mojarad E; Salari S; Rezvani H; Asadzadeh-Aghdaei H; Ladomery M; Young C; Anaraki F; Almond S; Ashrafian Bonab M
Cancer Inform; 2020; 19():1176935120972383. PubMed ID: 33239858
[TBL] [Abstract][Full Text] [Related]
17. A Mouse Model for the Rapid and Binomial Assessment of Putative WNT/β-Catenin Signalling Inhibitors.
Tse J; O'Keefe R; Rigopolous A; Carli ALE; Waaler J; Krauss S; Ernst M; Buchert M
Biomedicines; 2023 Oct; 11(10):. PubMed ID: 37893093
[TBL] [Abstract][Full Text] [Related]
18. Urantide alleviates atherosclerosis-related liver and kidney injury via the Wnt/β-catenin signaling pathway in ApoE(-/-) mice.
Xu YH; Xie JY; Huang S; Wang T; Cui HP; Zhao J
Herz; 2023 Nov; ():. PubMed ID: 37985514
[TBL] [Abstract][Full Text] [Related]
19. Sulfation of chondroitin and bile acids converges to antagonize Wnt/
Xu P; Xi Y; Kim JW; Zhu J; Zhang M; Xu M; Ren S; Yang D; Ma X; Xie W
Acta Pharm Sin B; 2024 Mar; 14(3):1241-1256. PubMed ID: 38487006
[TBL] [Abstract][Full Text] [Related]
20. Elevated expression of Axin2 in intestinal metaplasia and gastric cancers.
Lee DH; Jeong IH; Jang B
J Pathol Transl Med; 2023 Nov; 57(6):315-322. PubMed ID: 37926983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
